Patricia A. Schleckser

3-Year Follow-Up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) Trial

David R. Holmes, Paul S. Teirstein, Lowell F. Satler et al. · JACC: Cardiovascular Interventions · 2008 · 60 citations

Endovascular Technique, Cardiovascular Disease, Peripheral Intervention +7

Whole Blood Platelet function Assay on the /CHOR^TM Point-of-Care Hematology Analyzer

David G.M. Carville, Patricia A. Schleckser, Kirk E. Guyer et al. · Journal of ExtraCorporeal Technology · 1998 · 43 citations · Full text

Platelet Pathobiology, Whole Blood, Thrombosis +18

Whole blood platelet function assay on the ICHOR point-of-care hematology analyzer.

David G.M. Carville, Patricia A. Schleckser, Kirk E. Guyer et al. · PubMed · 1998 · 36 citations

Platelet Aggregation, Thrombosis, Laboratory Hematology +19

Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

Jeffrey W. Moses, Eugenia Nikolsky, Roxana Mehran et al. · The American Journal of Cardiology · 2006 · 30 citations

Percutaneous Coronary Intervention, Endovascular Technique, Cardiovascular Disease +6

Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial

Oluseun Alli, Paul S. Teirstein, Lowell F. Satler et al. · American Heart Journal · 2012 · 27 citations

Five-year Follow-up, Endovascular Technique, Cardiovascular Disease +6